new retatrutide Demand for Unapproved Weight-Loss Drug Surges on Social Media Retatrutide FDA Approval Status 2026:

If you have medullary thyroid cancer or genetic testing that puts you at risk for thyroid cancer, or you have a family member who has medullary thyroid cancer, they say you shouldn't use these drugs

But hormone therapy has been found to reduce osteoporosis risk in some patients

The Peterson-KFF Health System Tracker reports that the list price for Wegovy in the United States is approximately $1,349 per month, while Ozempic costs approximately $936 monthly before insurance adjustments

13 Mar 2023

Patent protection : GLP-1 medications are still under patent, which means there are no low-cost generic versions yet, and are only sold by the brand-name pharmaceutical company that manufactures them